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ABSTRACT 
Objective:  Cancer  cells  exhibit  altered  local  dielectric  properties  compared  to  normal  cells.  These  properties  are 
measurable  as  a  difference  in  electrical  conductance  using  electrical  impedance  scanning  (EIS).  EIS  is  at  present  not 
sufficiently  accurate  for  clinical  routine  despite  its  technological  advantages.  To  modify  the  technology  and  increase  its 
accuracy,  the  factors  that  influence  precision  need  to  be  analysed  and  identified.  While  size,  depth,  localisation  and 
invasiveness affect sensitivity, vascularisation might show an increased conductance and thus might affect specificity. 
Subjects and Methods: All patients were investigated with EIS (TransScan TS 2000, Migdal Ha Emek, Israel) Planned 
DCE MRI prior to histological clarification were included (295 lesions). Dynamic enhancements were assigned scores after 
analysis of subtracted images after application of Gd DTPA. D1: strong enhancement of >100% from initial signal obtained on 
native T1weighted sequence; D2: moderate enhancement 50 100%; D3: enhancement similar to glandular tissue, <50%; D4: 
subtle or no enhancement, less then surrounding glandular tissue. 
Results: 89/113 malignant and 107/182 benign findings were visible by a focal increased conductance and/or capacitance 
using EIS (Sensitivity 79%, Specificity 59%). DCE MRI was aborted due to claustrophobia in 17/295 cases. MR was used and 
out of 278 completed MR examinations, 101/104 malignant and 141/174 benign lesions were correctly diagnosed as benign or 
malignant leading to a sensitivity of 97% and a specificity of 81%. D1 benign lesions were positive in EIS in 33/55 cases 
suggesting a specificity of 44.4%. This value increases significantly with decreased vascularity to 68.9% (D2 4; 82/119). Out 
of 60 fibroadenomatous lesions, 10/23 fibroadenomas in class 1 had no focal increased conductance or capacitance and were 
thus considered as non suspicious in EIS. The same result was applicable for the 29/37 benign lesions with a D2 4 contrast 
uptake (43.5% vs. 78.4%, p<.01).  
Conclusion: Vascularisation influences the measurable conductance at low frequency and therefore partially causes the 
insufficiently low specificity of EIS. Impedance measurements at frequencies in a range of 0.1 KHz to 1 MHz are required . 
According to theoretical and in vitro studies this might increase the accuracy of EIS technology. © 2007 Biomedical Imaging 
and Intervention Journal. All rights reserved. 
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INTRODUCTION 
The  discrepancy  in  electrical  capacitance  of 
different types of tissue was first reported in the 1920s, 
reflecting the varying tissue characteristics of malignant 
tissue [1]. In the normal breast, moderate variations in 
impedance  values  are  observed,  expressing  the 
differences among various types of breast tissue [1]. In 
contrast to these observations in normal tissue, malignant 
tumours  show  substantially  increased  capacitance  and 
conductivity values resulting in decreased impedance [2, 
3].  These  discrepancies  are  attributed  to  changes  in 
cellular  water  content,  amount  of  extracellular  fluid, 
packing density, destruction of tight junctions and cell 
membranes and a changed orientation of malignant cells 
[4]. Depending on the frequency used for calculations, 
the  currently  available  technology  TransScan  TS  2000 
(ISRAEL)  allows  a  calculation  mainly  in  the 
extracellular area by using a low frequency range. 
Some studies report various sensitivity values even 
though EIS was used in a similar study design [6, 7, 8, 9, 
10]. In order to improve the accuracy of this technology, 
the knowledge of influencing factors is required. 
Therefore,  recently  published  studies  focused 
mainly  on  sensitivity  influencing  factors:  size,  depth, 
geometry and invasiveness that influence sensitivity are 
examples. In contrast to these studies, reasons for rather 
moderate  specificity  were  mainly  attributed  to  skin 
artefacts.  It  is  questionable  whether  benign  structures 
induce field imbalances (vortexes) by their bioelectrical 
properties.  At  low  frequencies,  the  vessel  walls  could 
potentially  act  as  insulators  and  thus  would  not 
contribute  to  conductance.  As  stated  by  Tofts  et  al., 
quantitative characterisation of the enhancement curves 
requires  a  complete  understanding  of  the  underlying 
physiological  mechanisms,  associated  with  the 
generation of the enhancement curve.  As discussed by 
Tofts, the space into which Gd DTPA can leak from the 
tumour  capillaries  probably  includes  the  extracellular 
space. This is the key structure to be measured by low 
frequency impedance calculations. 
Tofts’ studies proved that permeability of a tumour 
can be derived from the contrast uptake and from T1w 
images. Permeability, however, influences transmittance 
which  can  be  detected  theoretically  even  at  low 
frequencies.  
According  to  Tofts’  analysis,  highly  vascularised 
lesions  are  characterised  by  a  significantly  increased 
permeability.  Therefore  a  higher  vascularisation  might 
lead to an increased conductance because of the higher 
permeability of the cell membranes. The study analysed 
whether  the  vascularisation  of  lesions  influenced  the 
specificity or not. 
PATIENTS AND METHODS 
A retrospective study design was used. All patients, 
who underwent electrical impedance scanning due to a 
suspicious finding in mammography and ultrasound, and 
who additionally had a DCE MRI prior to histological 
clarification were included in the analysis. 
In total 113 malignant and 182 benign findings were 
included.  
EIS principle and measurement  
A low level electrical voltage was applied to a metal 
cylinder  that  patients  held  in  their  hands  while  in  a 
supine position. A cutaneous scan probe was placed at 
the region of interest exactly above the suspicious lesion. 
This  was  carried  out  under  sonographic  guidance.  We 
used  special  ultrasound  gel  as  recommended  by 
TransScan®  to  accomplish  a  steady  contact  with  an 
electrical  current  flowing  through  the  patient’s  body 
from the metal cylinder to the scan probe.  
It can be assumed, that during passage through the 
breast, the electrical field and thus current distribution 
was  quite  homogeneous,  because  the  healthy  breast 
tissue  was  approximated  as  uniform.  In  contrast  to 
healthy tissue, malignant lesions are characterised by a 
higher conductivity disturbance within the healthy tissue. 
In case of a disturbance of the electric field, i.e., due to 
the  existence  of  a  tumour,  the  electrical  field  will  be 
disturbed as well. If this lesion is located next to the skin, 
the  disturbance  can  be  measured  by  a  focal  increased 
density  of  current  and  thus  an  increased  focal 
conductance.  The  values  of  transmittance  on  the  same 
electrode array at 200 Hz were interpolated, and finally 
displayed in real time as a grey level impedance  map. 
According  to  our  own  studies,  lesions  to  a  depth  of 
30mm can be detected. Simulations made by Scholz and 
coworkers  demonstrated  a  detectability  of  lesions  to  a 
depth of 4 cm. Due to many influencing factors, absolute 
values of conductance and capacitance are less relevant 
because they vary significantly among different patients 
due  to  heterogeneity  of  skin  impedance,  different 
pressure  of  the  hand  held  probe  (varying  contact), 
different  skin  moisture,  different  sizes  of  field 
disturbances, different depths of the lesions from the skin 
surface and different tissue composition of the examined 
breasts.  
Absolute  values  of  each  electrode  are  therefore 
automatically calculated over a mean by the system. The 
resulting  values  are  transferred  into  256  different  grey 
levels.  If  the  value  of  one  or  several  corresponding 
electrodes is higher than the mean of all electrodes, they 
are displayed as more luminous in the resulting image 
than the values obtained from the surrounding electrodes. 
Consequently  such  increased  conductance  values  are 
visible as a lucent, enhancing spot. Examples of a focal 
enhanced structure and a non enhanced calculation are 
given in Figure 2. 
In  our  setup,  analysis  of  EIS  was  performed 
immediately  after  the  ultrasound  examination.  The 
position  of  the  patient  was  unchanged.  Therefore  the 
radiologist was not ignorant of the mammographic and 
sonographic  analysis.  Ethical  board  approval  was 
obtained. The technology used was approved by FDA.  A Malich et al. Biomed Imaging Interv J 2007; 3(4):e33    3 
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The  scan  probe  contains  a  planar  array  of  8x8 
sensors. Each sensor is 3 mm x 3 mm in size. The centre 
to centre distance is about 4 mm, thus leaving a gap of 1 
mm  between  adjacent  electrodes  (Figure  1).  Good 
contact  both  on  the  probe  and  the  metal  cylinder  is 
facilitated  with  the  use  of  ultrasound  gel.  The  sensor 
consists of a matrix of electrodes on the scan probe. It 
measures  electrical  currents  (current  distribution  and 
indirectly  voltage  and  resistivity  applying  frequencies 
ranging from 200 5000Hz). The only frequency used for 
analysis  is  200  Hz.  Examples  of  EIS  calculations  are 
given in Figure 2.  
One examination lasted approximately 5 minutes. 
Skin lesions, scars, moles, contact artefacts, bone, or 
air  bubbles  can  induce  spot like  results  and  thus 
influence the specificity.  
MR procedure 
MR was performed after mammography, ultrasound 
and EIS by a different radiologist, who was not meant to 
be  unaware  of  the  previous  mammography  and 
ultrasound results but was also not informed regarding 
the  EIS.  A  predefined  MR  examination protocol  was 
used and applied for all patients. All MR images were 
obtained with a 1.5 Tesla machine using a double breast 
coil, with the patient in a prone position.  
Multislice 2D Flash T1 weighted images served as a 
sequence  for  the  dynamic  study.  After  acquisition  of 
precontrast  images,  Gd DTPA  (Magnevist,  Schering, 
Germany) was administered intravenously (0.1 mmol/kg) 
as a rapid bolus within 10 seconds followed by 20 ml 
saline flush. 35 seconds after bolus injection and saline 
administration, dynamic scanning was continued in the 
same sequence and under identical tuning conditions at 
1 minute intervals for a total of 8 minutes. Precontrast 
T1  weighted  images  of  the  dynamic  study  were 
subtracted  from  the  postcontrast  dynamic  T1  weighted 
images.  The  vascularisation  was  scored  according  to 
time intensity curves. Therefore a region of interest (ROI) 
was placed on the area of the enhancing lesion with the 
most  suspicious  contrast  uptake  according  to  ACR 
recommendations. The analysis was adapted to the ACR 
criteria of enhancement and to the Fischer score used for 
differentiation  of  breast  lesions  in  DCE MRI.  The 
density value obtained on the native T1 weighted scan 
was taken and subtracted from the density value obtained 
on exactly the same position on the T1 weighted image 
performed  1  minute  after  contrast  uptake  according  to 
the recommendations of Kaiser et al. and ACR.  
Lesion contrast uptake was scored as follows:  
●  D1: initial enhancement >100% 
●  D2: initial enhancement 50 100%,  
●  D3: initial enhancement <50%, uptake similar 
to the surrounding breast tissue. 
●  D4:  subtle  or  no  enhancement,  lower  then 
surrounding tissue.  
Automated motion correction was not applied. Few 
cases had to be excluded due to severe motion artefacts 
on  related  irregular  conditions  to  place  the  region  of 
interest on exactly the same anatomical  structure prior 
and after contrast application.  
RESULTS 
EIS overall performance parameters 
89  of  113  histologically  proven  malignant  lesions 
were detected by a focal increased conductance and/or 
capacitance.  
107 of 182 benign lesions revealed a homogeneous 
conductance  and  capacitance  (and  thus  no  spot)  using 
EIS. But 75 of the histologically proven benign lesions, 
showed a focal enhancing pattern similar to a malignant 
lesion and therefore were judged falsely positive. 
 
Figure 1  Image of both views of a probe of the EIS technology A Malich et al. Biomed Imaging Interv J 2007; 3(4):e33    4 
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In the classification of equivocal suspicious lesions, 
EIS  achieved  an  overall  sensitivity  of  78.8%  and  a 
specificity  of  58.8%.  Negative  and  positive  predictive 
values  were  81.7%  and  54.3%,  respectively.  Accuracy 
was calculated as 68.8%. 
MR overall performance parameters 
17 out of the 295 examinations had to be aborted 
mainly due to claustrophobia and severe motion artefacts. 
Thus,  MR results  are  available  for  278  lesions  only. 
Using  DCE MRI  101/104  malignancies  and  141/174 
benign lesions were correctly detected after analysis of 
dynamic  and  morphologic  features  suggesting  a 
sensitivity  of  97.1%  and  a  specificity  of  81.0%. 
Consequently,  positive  and  negative  predictive  values 
were  75.4%  (calculated  as  101/(101+33))  and  97.9% 
(141/(141+3)) respectively. Accuracy of DCE MRI was 
89.1% ((97.1%+81.0%)/2).  
Mean size of benign and malignant findings did not 
differ significantly (sizes calculated using T1 weighted 
post enhancement images: 18mm and 17mm in the mean, 
respectively). 
EIS-Performance of malignant lesions in relation to 
vascularity 
Out  of  the  113  malignant  lesions  (including 
carcinomata  in  situ),  100  were  classified  as  D1  and  4 
lesions as D2 4. The remaining malignant lesions were 
not  classifiable  (reasons  are,  as  given  above 
claustrophobia, obesity). Out of the D1 lesions, a focal 
enhanced conductance was observed in 81 cases (81%). 
Of the four lesions classified as D2 4, one (D3) had the 
same focal enhanced conductance value. 
EIS-Performance of benign lesions in relation to 
vascularity 
Of the 174 benign lesions with an MR examination 
and  an  EIS examination,  55  were  classified  as  D1,  of 
which  EIS  showed  a  positive  focal  increased 
conductance  in  33  lesions,  suggesting  a  specificity  of 
40.0%.  
Among the 24 verified benign lesions of category 
D4, 6 were positive in EIS suggesting a specificity of 
75.0%. 
Comparing  D1  versus  all  other  lesions  (D2+3+4), 
specificity differs significantly: 40.0% vs. 68.9% (22/55 
and 82/119 lesions) according to Fisher’s t test. 
EIS-Performance of fibroadenomatous changes in 
relation to its vascularity 
The largest group of histologically verified lesions 
included  fibroadenomas.  Of  these  60  lesions,  23  were 
classified as D1 of which 10/23 revealed a homogeneous 
field in EIS, resulting in a specificity of 43.5%. Of the 
other 37 lesions, 29 showed a homoegeous image in EIS, 
therefore suggesting a specificity of 78.4%. 
 
          
 
 
(a)                                                   (b) 
Figure 2  Example  of  a)  a  positive  and  b)  a  negative  signal  (upper  quadrant  capacitance,  lower  quadrant 
conductance) of an electrical impedance image. A Malich et al. Biomed Imaging Interv J 2007; 3(4):e33    5 
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Using  Fisher’s  t test,  the  differences  between  D1 
and  D2 4  on  fibroadenomatous  tissue  are  significant 
(p<.01). 
DISCUSSION 
General  performance  of  Electrical  Impedance 
Scanning compared to DCE MRI 
As proven in our study as well as in other studies, 
DCE MRI is highly sensitive in the detection of invasive 
malignancies and reveals a high specificity. The major 
weaknesses  of  DCE MRI  are  unavailability,  length  of 
procedure and monetary costs. 
Hence  electrical  impedance  scanning  could  be  of 
interest as a cheap and fast technology to be used as an 
adjunctive examination in those cases where DCE MRI 
is  not  available  or  where  an  MR examination  is 
contraindicated. 
According to our experience, the sensitivity of EIS 
in  its  current  application  mode  is  definitely  unable  to 
achieve  the  impressive  sensitivity  (98%;  16)  and 
specificity values documented for DCE MRI, even if all 
currently  known  limitations  are  taken  into  account.  In 
order to improve EIS, some modifications are necessary: 
Vascularisation seems to influence the detection rate 
of  EIS.  Therefore  benign  lesions  with  a  relevant 
disturbance  of  the  electric  field  cause  false  positive 
conductance  values.  Due  to  the  study  design,  the 
documented correlation between these two factors does 
not inevitably imply a cause effect relationship. However, 
no  other  study  has  investigated  this  influence,  so  far. 
Furthermore  the  number  of  implemented  histologically 
verified lesions with associated MR examination allows 
a statistical analysis. 
Consequently, the result of this study proposes, that 
the low specificity is not only caused by several mainly 
skin associated artefacts, but also by some of the lesions 
being analysed. This result concurs with several in vitro 
studies. 
It is necessary to detect benign lesions that induce 
changes  in  homogeneity  in  the  electric  field  and  thus 
result in a positive EIS result. It is equally necessary to 
detect  malignant  and  premalignant  lesions  that  are  not 
associated with a detectable inhomogeneity of electrical 
field. Furthermore, alternative factors that lead to poor 
specificity have to be seriously considered and embedded 
in future technological improvements. A few suggestions 
to enable developments in EIS will be discussed:  
1.  Jossinet  and  coworkers  reported  altered 
conductance  and  capacitance  during  different  applied 
frequencies depending on the underlying histopathology. 
Therefore the analysis of the impedance in a range of 
frequencies including frequency values of the beta range 
could solve the problems of highly vascularised lesions, 
which  include  the  wrongly  detected  benign  lesions  in 
EIS. Early prototypes have been built to analyze this in 
vivo in a frequency range of up to 1 MHz [25]. 
2.  One further limitation of currently available EIS 
is  that  low  frequency  current  does  not  pass  cell 
membranes. This is the reason why intracellular changes 
cannot  be  obtained  by  EIS  in  the  current  available 
version.  Jossinet  and  coworkers  published  results 
analysing  impedivity  of  breast  tissue  over  a  frequency 
range [3, 5, 21]. As a result of their studies a divergence 
of the values within the range 10 kHz to 1 MHz can be 
apostrophised.  Due  to  the  fact  that  the  conductivity 
frequency relation is tissue characteristic [3, 21,22, 23], 
further  information  can  be  obtained  by  the  calculated 
parameters including intracellular changes allowing the 
discrimination of malignant and benign lesions [3, 5, 24]. 
This explains the inability of EIS to detect non invasive 
premalignant structures.  
3.  Additionally  a  high  number  of  different 
artefacts, mainly associated with the skin surface (scars, 
hairs,  bones,  contact  problems,  etc.)  reduce  the 
specificity  of  EIS,  as  was  demonstrated  in  this  study. 
Therefore improvements should implement the option to 
determine  the  impedance  values  in  various  distances 
from  the  skin.  By  doing  so  the  observer  could  match 
ultrasound  performance  in  peak  conductance  and  the 
depth  of  this  peak inducing  lesion..  The  proof  of  this 
principle was carried out in vitro as well as on clinical 
cases  using  post processing  algorithms  (multisignal 
analyses) [17].  
Due to electrophysiological reasons, skin associated 
alterations  of  conductance  cannot  induce  artefacts  in 
higher  frequency ranges  to  the  same  extend  as  in  low 
frequencies. Taking those aspects into account, the high 
frequency  analysis  of  lesions  offers  further  diagnostic 
potential. 
4.  The  EIS  technique  measures  the  current  flow 
(interpolated by computers into changes of conductivity 
and  capacitance).  If  the  tumour  size  is  large,  the 
conductance  of  several  electrodes  on  the  scanner 
increases thus increasing the mean value of conductance 
over  all  sensors.  Spot like  enhanced  peaks  cannot  be 
expected in this case and a rather homogeneous brighter 
area will be displayed because the relative differences of 
conductance  between  closely  located  electrodes  are 
smaller.  This  explains  why  larger,  homogeneously 
structured lesions do not induce a visible focal increase 
of  electrical  parameters  and  may  eventually  provide 
negative  EIS  results  and  thus  a  lowered  sensitivity. 
Unfortunately,  until  now  neither  size  nor  depth 
information has been taken into account while comparing 
absolutely  measured  values  with  already  histologically 
verified lesions.  
5.  The  different  vascularity  of  a  breast  lesion 
forms an input for low frequency impedance calculations 
and  thus  influences  the  EIS result.  Using  MR, 
vascularisation of lesions can be obtained starting with 
(at least 3mm) due to the tumour neoangiogenesis being 
induced from this size on. It can be verified, that similar 
to MR, EIS (under optimal circumstances) allows tumour 
detection starting from this size [18]. The most obvious 
reason seems to be, that vascularisation / permeability of 
tumours and therefore the extracellular content is altered 
due to neoangiogenesis. A Malich et al. Biomed Imaging Interv J 2007; 3(4):e33    6 
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In contrast to other imaging modalities, MR detects 
a change in the signal after contrast application versus a 
pre contrast  value.  It  can  be  assumed,  that  vascular 
density,  permeability  as  well  as  neovascularity  are 
associated with the extent and character of this contrast 
uptake.  However,  more  detailed  analyses  require 
pathological  verifications  which  were  completed  when 
dynamic  MR  was  introduced  [19,  20].  It  is  widely 
accepted  today,  that  contrast  enhancement  of  breast 
lesions is an important diagnostic feature that reflects the 
angiogenesis of the tumour. 
For  the  very  first  time,  recently  established,  new 
CAD  systems  allow  a  clear  identification  of  contrast 
uptake of the entire enhancing breast lesion. This new 
feature may reveal further options in the comparison of 
vascularisation,  perfusion  and  impedance  of  breast 
lesions  [26].  Tofts  and  coworkers  proved,  that 
permeability of a breast lesion, and thus the impedance, 
is  closely  related  to  the  dynamic  pattern  obtainable  in 
MRI [26].  
SUMMARY 
Electrical  impedance  scanning  shows  promising 
potential for further evaluation of equivocal suspicious 
mammographic and/or ultrasound findings, especially as 
an adjunctive diagnostic method. 
Vascularisation  of  lesions  influence  the  low 
frequency based calculation of conductance.  
Technological  developments  are  necessary  to 
address  factors  that  influence  EIS  performance.  The 
analysis  methodology  of  EIS  has  to  be  redefined  to 
include  depth  and  size dependent  analysis  options  and 
MUSIC based calculations. A range of frequencies up to 
1 MHz have to be implemented in the analysis.  
Due to its high accuracy and sensitivity, DCE MRI 
is  the  method  of  choice  in  the  discrimination  of 
equivocal  and  suspicious  breast  findings  despite  its 
limitations and rather high costs.  
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